|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Medical Game-Changers Beckonover 9 years ago
Investing in Africa: How to Do It Rightover 9 years ago
The Winning Edge in Emerging Marketsover 9 years ago
Paula Apsell: A Storied Life in Scienceover 9 years ago
Going to the Edgeover 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaover 9 years ago
Executive Pay and Innovationover 9 years ago
Science: The Communal Languageover 9 years ago
Will NICE ‘Go Commercial’?over 9 years ago
Country Report: MexicoAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
The Risks and Benefits of FDA Reviewing Real-Time Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5